Literature DB >> 2719314

Potentiation by mild hypothermia of ventricular conduction disturbances and reentrant arrhythmias induced by bupivacaine in dogs.

M Freysz1, Q Timour, R I Mazze, L Bertrix, S Cohen, K Samii, G Faucon.   

Abstract

High concentrations of bupivacaine and profound hypothermia individually cause intraventricular conduction disturbances and reentrant arrhythmias. The effects of the combination of relatively low concentrations of bupivacaine and mild hypothermia are unknown and are the subject of this study. Three groups (n = 10-12) of dogs anesthetized with thiopental-chloralose were treated as follows: group 1, bupivacaine + hypothermia; group 2, bupivacaine alone; group 3, hypothermia alone. Bupivacaine was administered as a 4 mg/kg iv bolus followed by an iv infusion of 0.1 mg.kg-1.min-1. Hypothermia, i.e., a 4 degrees C reduction in core temperature, was produced by cooling the blood with an extracorporeal circuit. The peripheral ECG was recorded to determine the duration of QRS complexes and the QT interval. Conduction time and effective refractory period (ERP) of ventricular contractile tissue were measured with right ventricular endocavitary electrodes. Measurements were made with the heart paced at 180 beats/min and without pacing. In group 1 dogs, bupivacaine (plasma level, 2.8 +/- 0.3 microgram/ml) initially caused a prolongation of conduction time and QRS duration, which were further lengthened (approximately doubled) by a temperature decrease of 4 degrees C from baseline. The QT interval and ERP also were increased but to a lesser degree. In dogs in which the effects were most pronounced, rhythm disorders, such as wave burst arrhythmias (most common), premature systoles, ventricular tachycardia, and even ventricular fibrillation, occurred either spontaneously or during pacing. Bupivacaine alone (group 2) increased QRS duration and conduction time significantly, whereas hypothermia alone (Group 3) did not cause changes in any conduction variables. In neither group were dysrhythmias observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2719314     DOI: 10.1097/00000542-198905000-00016

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  5 in total

1.  Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.

Authors:  J F Aupetit; Q Timour; J P Larbre; J Loufoua-Moundanga; I Kioueh; M Lopez; G Faucon
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

2.  Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.

Authors:  Q Timour; J F Aupetit; J Loufoua-Moundanga; I Gerentes-Chassagne; I Kioueh; G Faucon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

Review 3.  Pharmacokinetics of local anaesthetics in infants and children.

Authors:  Jean-Xavier Mazoit; Bernard J Dalens
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 4.  Temperature management in cardiac surgery.

Authors:  Hesham Saad; Mostafa Aladawy
Journal:  Glob Cardiol Sci Pract       Date:  2013-11-01

Review 5.  Intraoperative mild hypothermia for postoperative neurological deficits in people with intracranial aneurysm.

Authors:  Luying Ryan Li; Chao You; Bhuwan Chaudhary
Journal:  Cochrane Database Syst Rev       Date:  2016-03-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.